Pfizer is Buying a Cardiovascular Biopharma Company for $6.7Bn. Posted on December 20, 2021December 20, 2021 Share This https://thenationalpulse.com/news/pfizer-is-buying-a-cardiovascular-biopharma-company-for-6-7bn/?cc=acteng&cp=pdtk
